Terminated × Interventional × Neoplasm Metastasis × Clear all VOTRAGE
Phase 1 Terminated
18 enrolled
DICE
Phase 2 Terminated
7 enrolled
A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2 Terminated
188 enrolled
Study of Inlexisertib (DCC-3116) in Participants With RAS/MAPK Pathway Mutant Solid Tumors
Phase 1 Terminated
91 enrolled
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
Phase 1 Terminated
28 enrolled
Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Phase 1 Terminated
34 enrolled
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
Phase 2 Terminated
9 enrolled 10 charts
A Study of DS-9606a in Patients With Advanced Solid Tumors
Phase 1 Terminated
88 enrolled
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
Phase 1/2 Terminated
8 enrolled 13 charts
TSARINE
Phase 3 Terminated
13 enrolled
PRAMECE
Phase NA Terminated
52 enrolled
A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
35 enrolled
BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors
Phase 1 Terminated
99 enrolled
SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases
Phase NA Terminated
160 enrolled
MAST
Phase 1 Terminated
66 enrolled
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
Phase 1/2 Terminated
13 enrolled
CANOPY-1
Phase 3 Terminated
673 enrolled 38 charts
Tivozanib + Enzalutamide in Adv Prostate Cancer
Phase 2 Terminated
5 enrolled 7 charts
A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
Phase 2 Terminated
18 enrolled
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
Phase 1 Terminated
10 enrolled
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors
Phase 1 Terminated
21 enrolled
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Phase 1 Terminated
42 enrolled
A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Phase 2 Terminated
6 enrolled
PRIMING
Phase 1 Terminated
2 enrolled 10 charts
Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer
Phase 1 Terminated
3 enrolled
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Phase 1/2 Terminated
73 enrolled
Study of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)
Phase 1/2 Terminated
34 enrolled 44 charts
Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy
Phase 2 Terminated
19 enrolled
TOPOLOGY
Phase 2 Terminated
14 enrolled
POP-ART
Phase 1 Terminated
10 enrolled
A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Phase 1 Terminated
122 enrolled
KZR-261 in Subjects With Advanced Solid Malignancies
Phase 1 Terminated
61 enrolled 25 charts
HAMMER
Phase 1/2 Terminated
175 enrolled
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Phase 2 Terminated
77 enrolled 18 charts
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Phase 1/2 Terminated
95 enrolled
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
Phase 1 Terminated
36 enrolled 7 charts
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
Phase 1/2 Terminated
31 enrolled
CLAUDIO-01
Phase 1/2 Terminated
31 enrolled 34 charts
ARTIST
Phase 2 Terminated
36 enrolled
Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205)
Phase 2 Terminated
7 enrolled 10 charts
PAVO
Phase 2 Terminated
22 enrolled 17 charts
Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)
Phase 1/2 Terminated
70 enrolled 14 charts
A Study of ASP2074 in Adults With Solid Tumors
Phase 1 Terminated
23 enrolled
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Phase 1 Terminated
105 enrolled
Futibatinib in Patients With Specific FGFR Aberrations
Phase 2 Terminated
115 enrolled 19 charts
A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors
Phase 1 Terminated
23 enrolled
To Assess the Safety, Tolerability and Pharmacokinetics of INCB086550
Phase 1 Terminated
3 enrolled
SYS-CAPLIOX
Phase 1/2 Terminated
5 enrolled
Autologous TLPO Vaccine Basket
Phase 2 Terminated
63 enrolled